Hearing Screening Test Results of Newborns Conceived by Intracytoplasmic Sperm Injection: A Retrospective Study of Tertiary Referral Center

Yasemin Sert U., ÇELİK H., Canpolat F. E., Sımsek G. K., Engin Ustun Y.

Fetal and Pediatric Pathology, cilt.39, sa.4, ss.288-296, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1080/15513815.2019.1651804
  • Dergi Adı: Fetal and Pediatric Pathology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.288-296
  • Anahtar Kelimeler: Asssisted Reproductive Technologies, Hearing screening, ABR, TEOAE, IN-VITRO FERTILIZATION, OTOACOUSTIC EMISSIONS, FOLLOW-UP, REPRODUCTIVE TECHNOLOGIES, CHILDREN, INFANTS, RISK, IDENTIFICATION, INTERVENTION, IMPAIRMENT
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

© 2019 Taylor & Francis Group, LLC.Objective: Assisted reproductive technologies (ART), especially intracytoplasmic sperm injection (ICSI), is associated with birth defects. However, there are few reports on hearing screening tests of these babies. We aimed to determine the association between ART and hearing loss in newborns. Materials and methods: This retrospective study examined 246 ICSI newborns between 2013 and 2015. All the patients conceived by ICSI. We examined the hearing screening results of the babies. Results: A total of 25 newborns did not pass the first screening test, including 17 by transient evoked otoacoustic emission (TEOAE) and 8 by auditory brainstem response (ABR). Ten babies did not pass the advanced examination. Total hearing loss affected 4% of ART babies. Conclusion: Hearing screening tests exposed deficient results in 4% of ICSI babies, which is ten times more frequent than spontaneously conceived newborns.